The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Open accessAbstract
BACKGROUND: Drugs that selectively inhibit serotonin reuptake are effective treatments for adults with mood and anxiety disorders, but limited data are available on the safety and efficacy of serotonin-reuptake inhibitors in children with anxiety disorders. METHODS: We studied 128 children who were 6 to 17 years of age; who met the criteria for social phobia, separation anxiety disorder, or generalized anxiety disorder; and who had received psychological treatment for three weeks without improvement. The children were randomly assigned to receive fluvoxamine (at a maximum of 300 mg per day) or placebo for eight weeks and were evaluated with rating scales designed to assess the degree of anxiety and impairment. RESULTS: Children in the fluvoxamine group had a mean (+/-SD) decrease of 9.7+/-6.9 points in symptoms of anxiety on the Pediatric Anxiety Rating Scale (range of possible scores, 0 to 25, with higher scores indicating greater anxiety), as compared with a decrease of 3.1+/-4.8 points among children in the placebo group (P<0.001). On the Clinical Global Impressions-Improvement scale, 48 of 63 children in the fluvoxamine group (76 percent) responded to the treatment, as indicated by a score of less than 4, as compared with 19 of 65 children in the placebo group (29 percent, P<0.001). Five children in the fluvoxamine group (8 percent) discontinued treatment because of adverse events, as compared with one child in the placebo group (2 percent). CONCLUSIONS: Fluvoxamine is an effective treatment for children and adolescents with social phobia, separation anxiety disorder, or generalized anxiety disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite its positive effects, the use of paroxetine may have caused as side-effects insomnia, decreased appetite, vomiting, withdrawal, agitation, emotional liability and four patients described suicide ideations without attempting to consummate.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, fluvoxamine is considered effective and well tolerated in the long-term treatment of anxiety disorders with children and adolescents [40].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the fluvoxamine condition drop-out was higher (n = 5) than the placebo group (n = 2) due to sideeffects.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, studies examining the efficacy of fluvoxamine and sertraline have reported a significant reduction in the severity of the anxiety symptoms after only 12 weeks [37,59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional research suggests that combining psychotherapy with pharmacotherapy yields better outcomes than either approach alone, as psychotherapy can teach valuable skills in managing fear-inducing social situations while pharmacotherapy alleviates symptoms facilitating greater participation in behavioral interventions [60,61].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [60]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another study found that 76% of participants treated with fluvoxamine were classified as 'much improved,' compared to 29% in the placebo group [59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The participants allocated to the fluvoxamine experimental group benefited from a significant decrease in anxiety symptoms compared to the participants allocated to the placebo group.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“The most prevalent observed side-effects were headache, abdominal discomfort, increased motor activity and difficulty falling asleep.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236
Self-citationPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Self-citationSHAFFER, D., FISHER, P., DULCAN, M. K., DAVIES, M., PIACENTINI, J., SCHWAB-STONE, M. E., LAHEY, B. B., BOURDON, K., JENSEN, P. S., BIRD, H. R., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199607000-00012 · Cited by 1,587
Self-citationUsers' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.21.2598 · Cited by 1,185
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 971
Research works printed but not linked: 3
- Greenhill LL, 1998, Psychopharmacol Bull, 34, 155
- Walkup J, Davies M. The Pediatric Anxiety Rating Scale (PARS): a reliability study. In: Scientific proceedings of the 46th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 19–24, 1999:NR78. abstract.
- Wagner KD, Birmaher B, Carlson G, et al. Multi-center trial of paroxetine and imipramine in the treatment of adolescent depression. In: Scientific proceedings of the 45th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Anaheim, Calif., October 27–November 1, 1998:S12D. abstract.
Cited by
Sorted by citations
Items 101–200 of 589
White, L. K., Sequeira, S., Britton, J. C., Brotman, M. A., Gold, A. L., Berman, E., Towbin, K., Abend, R., Fox, N. A., Bar-Haim, Y., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16070847 · Cited by 96
Self-citationShechner, T., Britton, J. C., Ronkin, E. G., Jarcho, J. M., Mash, J. A., Michalska, K. J., Leibenluft, E., & Pine, D. S. (2014) · Depression and Anxiety · doi:10.1002/da.22318 · Cited by 97
Self-citationStrawn, J. R., Mills, J. A., Sauley, B. A., & Welge, J. A. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.015 · Cited by 98
Masia Warner, C., Colognori, D., Brice, C., Herzig, K., Mufson, L., Lynch, C., Reiss, P. T., Petkova, E., Fox, J., Moceri, D. C., et al. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12550 · Cited by 95
Self-citationCo-occurring Psychiatric Disorders in Children and Adolescents With Tourette Syndrome
Gaze, C. M., Kepley, H. O., & Walkup, J. T. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210081301 · Cited by 97
Self-citationEffectiveness of Modular CBT for Child Anxiety in Elementary Schools
Chiu, A. W., Langer, D. A., McLeod, B., Har, K., Drahota, A., Galla, B. M., Jacobs, J., Ifekwunigwe, M., & Wood, J. (2013) · School psychology quarterly · doi:10.1037/spq0000017 · Cited by 96
Martin, A., & LESLIE, D. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.757 · Cited by 96
Bilek, E. L., & Ehrenreich-May, J. (2012) · Behavior Therapy · doi:10.1016/j.beth.2012.04.007 · Cited by 108
Pilot Study of Community-Based Cognitive Behavioral Group Therapy for Adolescents With Social Phobia
BAER, S., & Garland, E. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00010 · Cited by 99
Brown, A. M., Deacon, B. J., Abramowitz, J. S., Dammann, J., & Whiteside, S. P. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.04.010 · Cited by 94
Comorbid Anxiety in Phenotypes of Pediatric Bipolar Disorder
Dickstein, D. P., Rich, B. A., Binstock, A., Pradella, A. G., Towbin, K. E., Pine, D. S., & Leibenluft, E. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.534 · Cited by 94
Self-citationStorch, E. A., Wood, J. J., Ehrenreich, J. T., Jones, A. M., Park, J. M., Lewin, A. B., & Murphy, T. K. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1489-9 · Cited by 93
Bearss, K., Taylor, C. A., Aman, M. G., Whittemore, R., Lecavalier, L., Miller, J., Pritchett, J., Green, B., & Scahill, L. (2016) · Autism · doi:10.1177/1362361315601012 · Cited by 88
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L. L., FAIRBANKS, J., KLEIN, R. G., Davies, M., Sweeney, M., Abikoff, H., et al. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386879 · Cited by 88
Self-citationCaporino, N. E., Brodman, D. M., Kendall, P. C., Albano, A. M., Sherrill, J. T., Piacentini, J. C., Sakolsky, D. J., Birmaher, B. B., Compton, S. N., Ginsburg, G. S., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.10.006 · Cited by 86
Self-citationSleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents
Caporino, N. E., Read, K. L., Shiffrin, N. D., Settipani, C. A., Kendall, P. C., Compton, S. N., Sherrill, J. T., Piacentini, J. C., Walkup, J. T., Ginsburg, G. S., et al. (2015) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2015.1063429 · Cited by 88
Self-citationPharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84
Treatment of comorbid anxiety and autism spectrum disorders
Nadeau, J. M., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., Ehrenreich, J. T., & Storch, E. A. (2011) · Neuropsychiatry · doi:10.2217/npy.11.62 · Cited by 85
Chamberlain, P. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0006 · Cited by 83
Mediators and Moderators of Outcome in the Behavioral Treatment of Childhood Social Phobia
Alfano, C. A., Piña, A., Villalta, I. K., Beidel, D. C., Ammerman, R. T., & Crosby, L. E. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181af8216 · Cited by 85
Reinblatt, S. P., dosReis, S., Walkup, J. T., & Riddle, M. A. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.040 · Cited by 81
Self-citationThe Utility of Clinicians Ratings of Anxiety Using the Pediatric Anxiety Rating Scale (PARS)
Ginsburg, G. S., Keeton, C. P., Drazdowski, T. K., & Riddle, M. A. (2010) · Child & Youth Care Forum · doi:10.1007/s10566-010-9125-3 · Cited by 81
Self-citationWarner, C. M., Colognori, D., Kim, R. E., Reigada, L. C., Klein, R. G., Browner-Elhanan, K. J., Saborsky, A., Petkova, E., Reiss, P., Chhabra, M., et al. (2011) · Depression and Anxiety · doi:10.1002/da.20821 · Cited by 75
“, selective serotonin reuptake inhibitors) have been shown to be effective for reducing anxiety in youth[21].”
BackgroundSelf-citationEscitalopram in Adolescents With Generalized Anxiety Disorder
Strawn, J. R., Mills, J. A., Schroeder, H. K., Mossman, S. A., Varney, S. T., Ramsey, L. B., Poweleit, E. A., Desta, Z., Cecil, K. M., & DelBello, M. P. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13396 · Cited by 84
Williams, L. E., Oler, J. A., Fox, A. S., McFarlin, D. R., Rogers, G. M., Jesson, M. A., Davidson, R. J., Pine, D. S., & Kalin, N. H. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.328 · Cited by 79
Self-citationUsing Evaluative Criteria to Review Youth Anxiety Measures, Part I: Self-Report
Etkin, R. G., Shimshoni, Y., Lebowitz, E. R., & Silverman, W. K. (2020) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2020.1802736 · Cited by 80
“The RCMAS, FSSC-R, SPAI-C, MASC, SCARED, and SCAS are the most widely used measures in treatment outcome research and each earn a rating of Excellent.”
BackgroundInfluentialNational Estimates of Antidepressant Medication Use Among U.S. Children, 1997-2002
Vitiello, B., Zuvekas, S. H., & NORQUIST, G. S. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000192249.61271.81 · Cited by 79
Self-citationReview of Safety Assessment Methods Used in Pediatric Psychopharmacology
Greenhill, L. L., Shockey, E. M., Davies, M., Fisher, P. W., Fried, J. E., Capasso, L., ROSENGARTEN, J., Vitiello, B., Riddle, M. A., VARIPATIS, E., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046841.56865.37 · Cited by 77
Self-citationEmotion Recognition Deficits in Pediatric Anxiety Disorders: Implications for Amygdala Research
Easter, J., Tone, E. B., Monk, C. S., Dhanani, M., Hodgdon, H., Leibenluft, E., Charney, D. S., Pine, D. S., & Ernst, M. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.563 · Cited by 83
Self-citationThe pathology of social phobia is independent of developmental changes in face processing
Blair, K. S., Geraci, M., Korelitz, K., Otero, M., Towbin, K., Ernst, M., Leibenluft, E., Blair, R. J. R., & Pine, D. S. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10121740 · Cited by 75
Self-citationPediatric Generalized Anxiety Disorder
Keeton, C. P., Kolos, A. C., & Walkup, J. T. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00003 · Cited by 81
Self-citationPost-traumatic stress disorder in children.
Kaminer, D., Seedat, S., & Stein, D. J. (2005) · PubMed Central · Cited by 74
Comorbidity and Child Psychopathology: Recommendations for the Next Decade
Jensen, P. S. (2003) · Journal of Abnormal Child Psychology · doi:10.1023/a:1023281513936 · Cited by 75
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Self-citationPredictors of treatment response in anxious-depressed adolescents with school refusal
LAYNE, A. E., BERNSTEIN, G. A., EGAN, E. A., & KUSHNER, M. G. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200303000-00012 · Cited by 73
Efron, D., Hiscock, H., Sewell, J. R., Cranswick, N., Vance, A. L. A., Tyl, Y., & Luk, E. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.372 · Cited by 73
The Food and Drug Administration’s Deliberations on Antidepressant Use in Pediatric Patients
Leslie, L. K., Newman, T. B., Chesney, P. J., & Perrin, J. M. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0074 · Cited by 73
Hamrin, V., McCarthy, E. M., & Tyson, V. (2010) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/j.1744-6171.2010.00237.x · Cited by 77
Childhood Social Anxiety Disorder: From Understanding to Treatment
Chavira, D. A., & Stein, M. B. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.05.003 · Cited by 71
Murray, M. L., Thompson, M., Santosh, P., & Wong, I. C. K. (2005) · Drug Safety · doi:10.2165/00002018-200528120-00009 · Cited by 71
Pharmacotherapy of social phobia
Davidson, J. R. T. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.7.x · Cited by 69
Child/Adolescent Anxiety Multimodal Study: Evaluating Safety
Rynn, M. A., Walkup, J. T., Compton, S. N., Sakolsky, D. J., Sherrill, J. T., Shen, S., Kendall, P. C., McCracken, J. T., Albano, A. M., Piacentini, J. C., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.12.015 · Cited by 72
Self-citationSertraline Pharmacokinetics and Dynamics in Adolescents
AXELSON, D. A., PEREL, J. M., BIRMAHER, B., RUDOLPH, G. R., NUSS, S., BRIDGE, J., & BRENT, D. A. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00003 · Cited by 70
Medication Use in Children and Adolescents Treated in the Community for Bipolar Disorder
Bhangoo, R. K., Lowe, C. H., Myers, F. S., Treland, J. E., Curran, J., Towbin, K. E., & Leibenluft, E. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322724904 · Cited by 68
Joseph, M. F., Youngstrom, E. A., & Soares, J. C. (2008) · Future Neurology · doi:10.2217/14796708.4.1.87 · Cited by 68
Depression in adolescence: A review
Beirão, D., Monte, H., Amaral, M., Longras, A., Matos, C., & Villas-Boas, F. (2020) · Middle East Current Psychiatry · doi:10.1186/s43045-020-00050-z · Cited by 70
“Paroxetine and fluvoxamine are not commonly used due to a lack of efficacy in this age group [65, 66].”
BackgroundStrawn, J. R., Wehry, A. M., DelBello, M. P., Rynn, M. A., & Strakowski, S. M. (2012) · Depression and Anxiety · doi:10.1002/da.21913 · Cited by 71
Cohen, D., Deniau, E., Maturana, A., Tanguy, M., Bodeau, N., Labelle, R. J., Breton, J., & Guilé, J.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002632 · Cited by 69
The pharmacological management of childhood anxiety disorders: a review
Reinblatt, S. P., & Riddle, M. A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0644-4 · Cited by 67
Self-citationPatel, D. R., Feucht, C., Brown, K., & Ramsay, J. (2018) · Translational Pediatrics · doi:10.21037/tp.2017.08.05 · Cited by 62
Steiner, H., Saxena, K., Carrión, V. G., Khanzode, L. A., Silverman, M. A., & Chang, K. (2007) · Child Psychiatry & Human Development · doi:10.1007/s10578-007-0055-8 · Cited by 67
Hardin, M. G., Mandell, D., Mueller, S. C., Dahl, R. E., Pine, D. S., & Ernst, M. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02121.x · Cited by 66
Self-citationUsing Evaluative Criteria to Review Youth Anxiety Measures, Part II: Parent-Report
Etkin, R. G., Lebowitz, E. R., & Silverman, W. K. (2021) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2021.1878898 · Cited by 65
Psychosocial Treatment of Irritability in Youth
Kircanski, K., Clayton, M., Leibenluft, E., & Brotman, M. A. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0141-5 · Cited by 67
The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression
Findling, R. L., McNamara, N. K., Stansbrey, R. J., Feeny, N. C., Young, C. M., Peric, F. V., & Youngstrom, E. A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.131 · Cited by 64
Community-Based Interventions in a System of Care and Outcomes Framework
Duchnowski, A. J., Kutash, K., & Friedman, R. M. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0002 · Cited by 64
Haller, S. P., Kircanski, K., Stringaris, A. K., Clayton, M., Bui, H. N. T., Agorsor, C. F., Cárdenas, S. I., Towbin, K. E., Pine, D. S., Leibenluft, E., et al. (2019) · Behavior Therapy · doi:10.1016/j.beth.2019.10.005 · Cited by 62
Self-citationAntidepressants use in children and adolescents and the risk of suicide
Wohlfarth, T. D., van Zwieten, B. J., Lekkerkerker, F. J. F., Wied, C. C. G., Ruis, J. R., Elferink, A. J. A., & Storosum, J. G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.004 · Cited by 62
Diffusion of efficacious interventions for children and adolescents with mental health problems
Graeff‐Martins, A. S., Flament, M. F., Fayyad, J. A., Tyano, S., Jensen, P. S., & Rohde, L. A. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01827.x · Cited by 64
Olvera, R. L., Semrud‐Clikeman, M., Pliszka, S. R., & O’Donnell, L. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00167.x · Cited by 65
Pharmacotherapy for anxiety disorders in children and adolescents
Kodish, I., Rockhill, C., & Varley, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/ikodish · Cited by 62
Development of Stepped Care Trauma-Focused Cognitive-Behavioral Therapy for Young Children
Salloum, A., Scheeringa, M. S., Cohen, J. A., & Storch, E. A. (2013) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2013.07.004 · Cited by 64
Steyaert, J. G., & la Marche, W. D. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0764-4 · Cited by 63
Treatment of Separation, Generalized, and Social Anxiety Disorders in Youths
Mohatt, J. W., Bennett, S. M., & Walkup, J. T. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101337 · Cited by 65
Self-citationPharmacotherapy of social anxiety disorder
Blanco, C., Antia, S. X., & Liebowitz, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01294-x · Cited by 88
An Open-Label Trial of Escitalopram in Children and Adolescents with Social Anxiety Disorder
Isolan, L., Pheula, G. F., Salum, G. A., Oswald, S. H., Rohde, L. A., & Manfro, G. G. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0007 · Cited by 60
Emerging Treatments for Child and Adolescent Social Phobia: AReview
Mancini, C., Ameringen, M. V., Bennett, M., Patterson, B. A., & Watson, C. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.589 · Cited by 62
Clark, D. B., Birmaher, B. B., Axelson, D., Monk, K., Kalas, C., Ehmann, M., Bridge, J. A., WOOD, D. S., Muthén, B., & Brent, D. A. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000183464.41777.c1 · Cited by 59
Mills, J. A., & Strawn, J. R. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.10.013 · Cited by 60
Efficacy and safety of antidepressant drug treatment in children and adolescents
Henry, A., Kisicki, M. D., & Varley, C. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.150 · Cited by 57
Psychopharmacologic Treatment of Children and Adolescents with Anxiety Disorders
Strawn, J. R., Sakolsky, D. J., & Rynn, M. A. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.05.003 · Cited by 58
Research in child and adolescent psychopharmacology: recent accomplishments and new challenges
Vitiello, B. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0414-3 · Cited by 58
Self-citationGothelf, D., Rubinstein, M., Shemesh, E., Miller, O. M., Farbstein, I., KLEIN, A., Weizman, A., Apter, A. S., & Yaniv, I. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000181042.29208.eb · Cited by 56
Vitiello, B. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200301000-00006 · Cited by 56
Self-citationManagement of Generalized Anxiety Disorder in Primary Care
Davidson, J. R. T., Feltner, D. E., & Dugar, A. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09r00772blu · Cited by 56
Strawn, J. R., Compton, S. N., Robertson, B., Albano, A. M., Hamdani, M., & Rynn, M. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0132 · Cited by 55
“Importantly, many (Walkup et al. 2001, 2008), but not all (Rynn et al. 2001, 2007; Strawn et al. 2015a), psychopharmacologic studies in children and adolescents have treated the pediatric anxiety triad as a monolith, rather than focusing on individual diagnoses.”
BackgroundSelf-citationHow Can We Improve the Assessment of Safety in Child and Adolescent Psychopharmacology?
Vitiello, B., Riddle, M. A., Walkup, J. T., Labellarte, M. J., VARIPATIS, E., Greenhill, L. L., Davies, M., Capasso, L., March, J. S., Levine, J., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046840.90931.36 · Cited by 55
Self-citationJohn, A. M., Marchant, A. L., McGregor, J., Tan, J. O. A., Hutchings, H. A., Kovess–Masféty, V., Choppin, S., Macleod, J., Dennis, M., & Lloyd, K. R. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.002 · Cited by 60
Anxiety in adolescents: Update on its diagnosis and treatment for primary care providers
Dickstein, D. P. (2011) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s7597 · Cited by 59
SEPARATION ANXIETY DISORDER IN YOUTH: PHENOMENOLOGY, ASSESSMENT, AND TREATMENT.
Ehrenreich, J. T., Santucci, L. C., & Weiner, C. L. (2008) · PubMed · doi:10.1901/jaba.2008.16-389 · Cited by 61
Separation Anxiety Disorder, Panic Disorder, and School Refusal
Suveg, C. M., Aschenbrand, S. G., & Kendall, P. C. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.05.005 · Cited by 57
Ferdinand, R. F., van Lang, N. D. J., Ormel, J., & Verhulst, F. C. (2005) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2004.12.003 · Cited by 51
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Martin, A., & LESLIE, D. L. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.997 · Cited by 50
Strawn, J. R., Mills, J. A., Cornwall, G. J., Mossman, S. A., Varney, S. T., Keeshin, B. R., & Croarkin, P. E. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0060 · Cited by 51
Fluvoxamine in the treatment of anxiety disorders
Irons, J. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a797 · Cited by 50
Pharmacotherapy for Anxiety Disorders in Children and Adolescents
Kodish, I. M., Rockhill, C., Ryan, S. A., & Varley, C. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.10.002 · Cited by 50
Intervention for autistic spectrum disorders
Filipek, P. A., Steinberg-Epstein, R., & Book, T. M. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.014 · Cited by 51
Drug-Induced Disinhibition in Psychiatrically Hospitalized Children
Carlson, G. A., & Mick, E. O. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322163871 · Cited by 50
Responses to Conflict and Cooperation in Adolescents with Anxiety and Mood Disorders
Tone, E. B., Parrish, J. M., Nelson, E. E., Easter, J. S., Thorne, J. F., Rilling, J. K., Ernst, M., & Pine, D. S. (2007) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-007-9113-8 · Cited by 51
Self-citationProspective open-label pilot trial of mirtazapine in children and adolescents with social phobia
Mrakotsky, C., Masek, B. J., Biederman, J., Raches, D., Hsin, O., Forbes, P., de Moor, C., DeMaso, D. R., & Gonzalez–Heydrich, J. (2007) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2007.01.005 · Cited by 49
Social Anxiety Disorder in Children and Adolescents: Epidemiology, Diagnosis, and Treatment
Khalid-Khan, S., Santibanez, M.-P., McMicken, C., & Rynn, M. A. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709040-00004 · Cited by 48
Muris, P., & Broeren, S. (2008) · Journal of Child and Family Studies · doi:10.1007/s10826-008-9242-x · Cited by 54
Hathaway, E. E., Walkup, J. T., & Strawn, J. R. (2018) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2017.12.002 · Cited by 48
Self-citationPanic Disorder and School Refusal
Hella, B., & Bernstein, G. A. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.05.012 · Cited by 51
The Child and Adolescent Psychiatry Trials Network (CAPTN)
March, J. S., Silva, S. G., Compton, S. N., Anthony, G., DeVeaugh-Geiss, J., Califf, R. M., & Krishnan, R. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200405000-00004 · Cited by 45
Self-citationMemory deficits in children with and at risk for anxiety disorders
Vasa, R. A., Roberson‐Nay, R., KLEIN, R. G., Mannuzza, S., Moulton, J. L., Guardino, M., Merikangas, A. K., Carlino, A. R., & Pine, D. S. (2006) · Depression and Anxiety · doi:10.1002/da.20193 · Cited by 44
Self-citationA DSM-IV—Referenced Teacher Rating Scale for Use in Clinical Management
Mattison, R. E., Gadow, K. D., Sprafkin, J. N., Nolan, E. E., & Schneider, J. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046813.95464.b3 · Cited by 43
Assessment and Treatment of Anxiety Among Children and Adolescents
Freidl, E. K., Stroeh, O. M., Elkins, R. M., Steinberg, E. J., Albano, A. M., & Rynn, M. A. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160047 · Cited by 56
Selective Serotonin Reuptake Inhibitors in pediatric psychopharmacology: A review of the evidence
Hammerness, P. G., Vivas, F., & GELLER, D. A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.09.028 · Cited by 43
Antidepressants in child and adolescent depression: where are the bugs?
Moreno, C., Arango, C., Parellada, M., Shaffer, D., & Bird, H. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00951.x · Cited by 44
Metadata
- Authors
- Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., Klee, B., McCracken, J., Bergman, L., Piacentini, J., March, J., Compton, S., Robinson, J., O'Hara, T., Baker, S., Vitiello, B., Ritz, L., & Roper, M.
- Affiliations
- New York State Psychiatric Institute (US)
- University of California, Los Angeles (US)
- Duke University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-04-26
- Volume
- 344
- Issue
- 17
- Pages
- 1279-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330595721
- Cited by
- 588
- References
- 42
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 18 · 2016: 17 · 2015: 19 · 2014: 20 · 2013: 23 · 2012: 23
- FWCI
- 73.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brown University
- Johns Hopkins University
- York University
- National Institutes of Health (n01mh060005-010, n01mh060016-007, n01mh070010-001)
- University of Illinois at Urbana-Champaign
- National Institute of Mental Health (N01 MH 70010, N01 MH60005, N01MH60016)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- fluvoxamine, selective serotonin reuptake inhibitors, childhood anxiety disorders, social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, children and adolescents, drug safety and efficacy, adverse events
- MeSH terms
- Adolescent, Anxiety Disorders, Anxiety, Separation, Child, Female, Humans, Male, Phobic Disorders, Psychotherapy, Anti-Anxiety Agents, Fluvoxamine, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
